DISCUSSION
The current study aimed at assessment of psychiatric morbidity among those with
diabetes in outpatient department in a tertiary care hospital (South India). Furthermore, we
aimed at exploring the correlation among diabetes related parameters like glucose levels and
psychiatric illness among the study subjects.
In this study, we found that approximately one third of patients with T2DM attending
diabetes centres suffer from likely depression and anxiety and that a substantial proportion
remain untreated. Patients with depression or anxiety were less likely to achieve the
recommendations for smoking cessation, diet, physical activity, and blood glucose
monitoring.
Majority of the study subjects 119s (79%) were found to be anxiety condition then
depression at the time of assessment. The subjects with depression were found to be 17%
(n=28). The distribution of depression in among subjects who are taking Insulin, OHA, both
were found to be 11.5%, 4.6% and 1%. The distribution of anxiety in subjects who are taking
Insulin, OHA, both were found to be 8%, 51.3% and 19.3% respectively. In our study we
tried to find the various types of psychiatric comorbidities with diabetes using MINI.6.0.2.
International Neuropsychiatric Scale. Unlike with the article (2) our study got more males than
females, majority of the subjects facing anxiety(79%) than the depression(17%) and subject
with insulin are more prone to get anxiety and depression than with oral hypoglycaemics.
Comparision of Anxiety in Diabetic patiets with respect to medications are found to
be those who are taking oral hypoglycemics, maximum subjects 77 ot of 119 are facing
generalised anxiety, subjects who are taking Insulin out of 15 members 12 members are
suffering with anxiety.
S.NO TYPE OF TREATMENT WITH WITHOUT TOTAL
ANXIETY ANXIETY
1 Insulin 12 (8%) 3 (2%) 16
2 Insulin+ oral 14 (9.3%) 2 (1.3%) 16
hypoglycemics
3 oral hypoglycemics 77 (51.3%) 42 (2.8) 119
Comparision of Depression in Diabetic patiets with respect to medications are found
to be those who are taking oral hypoglycemics ,subjects who are taking oral hypoglycemics
out of 118 members 19 members are suffering with depression.
S.NO TYPE OF TREATMENT WITH WITHOUT TOTAL
DEPRESSION DEPRESSION
1 Insulin 7 (4.6%) 9 (6%) 16
2 Insulin+ oral 2(1.33%) 14 (9.3%) 16
hypoglycemics
3 oral hypoglycemics 19(12.6%) 99 (66%) 118
T2DM negatively impacts health-related quality of life and satisfaction
with life.
This negative impact affects multiple aspects of a person’s life, including the psychological
impact of being chronically ill, dietary restrictions, changes in social life, symptoms of
inadequate metabolic control, chronic complications, and ultimately lifelong disabilities.
Satisfaction with life is a very important factor in the life of a patient with
T2DM. Satisfaction with life translates to better therapeutic effects and improvements in the
patient’s health. Health satisfaction is a unique and important concept to consider when
developing individualized strategies for managing T2DM because health satisfaction is a key
element of patient-centered care. The concept of diabetes-related health satisfaction
encompasses issues specifically related to living with diabetes (eg, blood glucose levels,
blood pressure levels, body weight). Health satisfaction is more specific than overall health-
related quality of life because it considers disease-related factors. It is different from diabetes
treatment satisfaction because it addresses issues not specifically related to treatment. Low
levels of health satisfaction in people with T2DM may negatively affect self-care behaviors
and treatment outcomes The study showed that health behaviors like proper eating habits,
preventive behaviors, positive mental attitude, and health practices have an enormous
influence on the patient’s satisfaction with life.
CONCLUSION
The current study aimed at assessment of psychiatric morbidity among those with
diabetes in outpatient department in a tertiary care hospital (South India). Furthermore, we
aimed at exploring the correlation among diabetes related parameters like glucose levels and
psychiatric illness among the study subjects.
In our study we have found that among 119 subjects 79% were suffering from anxiety
in which mostly are males compared to females and 28 subjects 17% were suffering from
depression. The distribution of depression in among subjects who are taking Insulin, OHA,
both were found to be 11.5%, 4.6% and 1% respectively. The distribution of anxiety in
subjects who are taking Insulin, OHA, both were found to be 8%, 51.3% and 19.3%
respectively.
REFERENCES:
1. P.Rajendra,Prerna.D,et.al., Assessment of depression and diabetic distress in diabetes mellitus in
a tertiary care hospital of south India, International journal of research in medical sciences(2017,
September 5) http:dx.doi.org/10.18203/2320-6012.ijrms20173696.
2. NitinJ, BhaskaranU,et.al., Proportion of depression and its determinants among diabetes mellitus
patient in various tertiary care hospital in Mangalore city of south India, Indian journal of
endocrinology and metabolism.,(2013, July to august). www.ijem.in10.103/2230-8210.113761.
3. Daniel D , Janne S. et.al., Increasing risk of psychiatric morbidity after childhood onset type 1
diabetes :a population bases cohort study .Springer -verlag Gmbh Germany (2017dec14)
https://dol.org/10.1007/s00215-017-4517-7.
4.NatalieN,et.al., Depression and diabetes distress in adult with type 2 diabetes: results from the
Australian National Diabetes Audit (ANDA)(2018, May18)..Sientific reports .10.1038/S41595-018-
26138-
5.Yatan.P,RajeshS,et.al.,Correlates of anxiety and depression among patients type 2 diabetes
mellitus. Indian journal of Endocrinology and metabolism(2011).www.ijem.in.10.4103/2230-
8210.83057.
6.PaeendaK, Neyha et.al., Incidence of anxiety and depression among patient with type-2 diabetes
and the predicting factors cureus(2019-march14)..10.7759/cureus.4254.
7.ChristinaN,et.al.,Psychologicalwellbeing and type 2 diabetes. HHS public access.(2017-
december2020) https://www.ncbi.nlm.nih.gov/PMC/articles/PMC573802
8.Mirelle C.Almedia,et.al., Psychiatric disorders in adolescents with type 1 diabetes: case
control study( 2018)Brazilian journal of psychiatry 10.1590/1516- -2017-2259ssssss
9. Kaitlyn Rechenberg, J.pediatr nurs: Anxiety in youth with Type-1 diabetes
(jan-feb-2017),https://pubmed.ncbi.nlm.nih.gov/10318745.
10. paola maffi et al.,The burden of diabetes: Global prevalence of diabetic emerging data
(2017),https://pubmed.ncbi.nlm.nih.gov/28427059/.
11.Khyati k Banker et al., The impact of diabetes on productivity in india (Dec.2021),
https://pubmed.ncbi.nlm.nih.gov/34675058/.
12.Ciechanowski PS, Katon WJ & Russo JE et al., Depression and diabetes: impact of depressive
symptoms on adherence, function, and costs. Archives of Internal Medicine(2000), 160, 3278–3285.
13. Creed F, Morgan R, Fiddler M, et al., Depression and anxiety impair health-related quality of life
and are associated with increased costs in general medical inpatients(2002). Psychosomatics, 43,
302–309.
14.DeGrootM, Anderson R, Freedland KE, et al., Association of depression and diabetes
complications: a meta-analysis(2001) Psychosomatic Medicine, 63, 619–630.
15.Dixon L, Weiden P, Delahanty J, et al., Prevalence and correlates of diabetes in national
schizophrenia samples(2000). Schizophrenia Bulletin, 26, 903–912.
16. Grey M, Boland EA, Davidson M, et al., Coping skills training for youth with diabetes mellitus
has long-lasting effects on metabolic control and quality of life(2000). Journal of Pediatrics, 137,
107–113.
17. Herpertz S, Johann B, Lichtblau K, et al. Patients with diabetes mellitus: psychosocial stress and
the use of psychosocial support: a multicentre study(2000). Medizinische Klinik, 95, 369–377 (in
German).
18. Lloyd CE, Matthews KA, Wing RR, et al. Psychosocial factors and complications of IDDM. The
Pittsburgh Epidemiology of Diabetes Complications Study. VIII. Diabetes Care,(1999) 15, 166–172.
19.Sullivan MD, O’Connor P, Feeny P, et al., Depression predicts all cause mortality:
epidemiological evaluation from the ACCORD HRQL Study(2012), Diabetes Care, 35, 1708–1715.
20.Gavard, J.A, Lustman, P.J. & Clouse, R.E et al.,. Prevalence of depression in adults with diabetes.
An epidemiological evaluation(1993), Diabetes Care 16, 1167–1178.
21. Lustman, P.J, Griffith, L.S., Freedland, K.E., Kissel, S.S. & Clouse, R.E et al., Cognitive
behaviour therapy for depression in type 2 diabetes: results of a randomized controlled clinical
trial(1998),Annals of Internal Medicine 129, 613–621.
22. Dipiro, pharmacotherapy: A pathophysiological approach ,sixth edition, by Mc.Graw-Hill
companies.
23.Ryan C, Vega A, Drash Aet al., Cognitive deficits in adolescents who developed diabetes early in
life(2007), Pesdiatrics 1985;75:921–927.
24.Lin EH, Katon W, Von Korff M, Rutter C, Simon GE, Oliver M, et al Relationship of depression
and diabetes self-care, medication adherence, and preventive care Diabetes Care(2010).
2004;27:2154–60
25.Eraker SA, Kirscht JP, Becker MH. Understanding and improving patient compliance Ann Intern
Med(1993). 1984;100:258–68
26. Katon WJ, Rutter C, Simon G, Lin EH, Ludman E, Ciechanowski P, et al The association of
comorbid depression with mortality in patients with type 2 diabetes Diabetes Care(2017).
2005;28:2668–72
27. Egede LE, Zheng D, Simpson K. Comorbid depression is associated with increased health care
use and expenditures in individuals with diabetes Diabetes Care(2002);25:464–70
28. Goldston DB, Kovacs M, Ho VY, Parrone PL, Stiffler L. Suicidal ideation and suicide attempts
among youth with insulin-dependent diabetes mellitus J Am Acad Child Adolesc Psychiatry.
(1994);33:240–6
29. Goldston DB, Kelley AE, Reboussin DM, Daniel SS, Smith JA, Schwartz RP, et al., Suicidal
ideation and behavior and noncompliance with the medical regimen among diabetic adolescents J
Am Acad Child Adolesc Psychiatry.( 1997);36:1528–36
30. McHale M, Hendrikz J, Dann F, Kenardy J. Screening for depression in patients with diabetes
mellitus Psychosom Med.( 2008);70:869–74
31. Al-Amer RM, Sobeh MM, Zayed AA, Al-Domi HA. Depression among adults with diabetes in
Jordan: Risk factors and relationship to blood sugar control J Diabetes Complications.
(2011);25:247–52
32. Black SA, Markides KS, Ray LA. Depression predicts increased incidence of adverse health
outcomes in older Mexican americans with type 2 diabetes Diabetes Care.( 2003);26:2822–8
33. James BO, Omoaregba JO, Eze G, Morakinyo O. Depression among patients with diabetes
mellitus in a Nigerian teaching hospital South Afr J Psychiatry. (2010);16:61–4
34. Lustman PJ, Harper GW. Nonpsychiatric physicians’ identification and treatment of depression
in patients with diabetes Compr Psychiatry. (1987);28:22–7
35. Lustman PJ, Griffith LS, Freedland KE, Kissel SS, Clouse RE. Cognitive behavior therapy for
depression in type 2 diabetes mellitus. A randomized, controlled trial Ann Intern Med.
(1998);129:613–21
36. Pyne JM, Rost KM, Zhang M, Williams DK, Smith J, Fortney J. Cost-effectiveness of a primary
care depression intervention J Gen Intern Med. (2003);18:432–41
37. Raval A, Dhanaraj E, Bhansali A, Grover S, Tiwari P. Prevalence and determinants of depression
in type 2 diabetes patients in a tertiary care centre Indian J Med Res.( 2010);132:195–200
38. Kumar N, Shekhar C, Kumar P, Kundu AS. Kuppuswamy's socioeconomic status scale-updating
for 2007 Indian J Pediatrics. (2007);74:1131–2
39. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-
MD: The PHQ primary care study. Primary care evaluation of mental disorders. Patient health
questionnaire JAMA. (1999);282:1737–44
40. Kochhar PH, Rajadhyaksha SS, Suvarna VR. Translation and validation of brief patients health
questionnaire against DSM IV as a tool to diagnose major depressive disorder in Indian patients J
Postgrad Med. (2007);53:102–7
